Palo Alto Investors LP - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 1 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,197,200
+22.0%
732,4000.0%0.21%
+42.5%
Q2 2023$1,801,704
+47.1%
732,400
+35.1%
0.15%
+44.6%
Q1 2023$1,225,146542,1000.10%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 111,550$274,4130.39%
Deep Track Capital, LP 2,837,818$6,981,0320.32%
apricus wealth, LLC 77,329$219,6140.19%
PARSONS CAPITAL MANAGEMENT INC/RI 873,312$2,148,3480.16%
Palo Alto Investors LP 732,400$1,801,7040.15%
RTW INVESTMENTS, LP 2,131,835$5,244,3140.10%
AdvisorShares Investments LLC 112,898$277,7290.08%
GSA CAPITAL PARTNERS LLP 271,524$6680.07%
Spotlight Asset Group, Inc. 20,000$49,2000.04%
Savior LLC 3,500$8,6100.04%
View complete list of RELMADA THERAPEUTICS INC shareholders